4D Molecular Therapeutics Inc.
FDMT | NASDAQ
$16.07
+$0.83 (+5.45%)
Sep 22, 2026, 2:09 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Cash & Equivalents | 60.24M | 149.34M | 249.11M | 52.35M | 153M | 276.73M |
Short-Term Investments | 342.41M | 275.54M | 39.12M | 161.2M | 94.78M | n/a |
Long-Term Investments | 111.38M | 80.58M | 10.95M | 4.91M | 67.65M | n/a |
Other Long-Term Assets | 9.19M | 4.26M | 684K | 1.08M | 602K | 602K |
Receivables | n/a | n/a | n/a | 700K | 47K | 1.49M |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 10.48M | 10.06M | 8.36M | 6.26M | 8.46M | 4.44M |
Total Current Assets | 413.13M | 434.93M | 296.59M | 220.51M | 256.28M | 282.66M |
Property-Plant & Equipment | 33.01M | 40.61M | 31.67M | 35.35M | 28.95M | 5.07M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 153.58M | 125.45M | 43.3M | 41.34M | 97.21M | 5.68M |
Total Assets | 566.71M | 560.38M | 339.89M | 261.85M | 353.49M | 288.33M |
Account Payables | 11.16M | 4.39M | 3.52M | 3.32M | 4.76M | 1.79M |
Deferred Revenue | 360K | 257K | 273K | 884K | 2.6M | 6.59M |
Short-Term Debt | n/a | n/a | n/a | 2.66M | n/a | n/a |
Other Current Liabilities | n/a | n/a | 3.87M | 3.18M | n/a | n/a |
Total Current Liabilities | 43.99M | 29.15M | 18.95M | 15.73M | 16.34M | 16.74M |
Long-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | 496K | 603K | 617K | 233K | 334K | 1.97M |
Total Long-Term Liabilities | 17.06M | 20.63M | 13.11M | 14.78M | 18.04M | 15.2M |
Total Liabilities | 61.05M | 49.78M | 32.06M | 30.51M | 34.38M | 31.94M |
Total Debt | 21.41M | 24.61M | 14.67M | 16.12M | 16.45M | n/a |
Book Value | 505.66M | 510.61M | 307.83M | 231.34M | 319.11M | 256.39M |
Book Value Per Share | 8.73 | 9.47 | 7.87 | 7.15 | 11.51 | 9.61 |
Common Stock | 6K | 5K | 4K | 3K | 3K | 3K |
Retained Earnings | -716.3M | -576.2M | -415.33M | -314.49M | -207M | -135.68M |
Comprehensive Income | 727K | 229K | 16K | -1.2M | -423K | -288.33M |
Shareholders Equity | 505.66M | 510.61M | 307.83M | 231.34M | 319.11M | 256.39M |
Total Investments | 453.79M | 356.12M | 50.08M | 166.11M | 162.43M | n/a |
Add to Watchlist
Select watchlists to add or remove FDMT